A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15.

Suppr

超能文献

作者信息

Sachse C, Brockmöller J, Bauer S, Reum T, Roots I

机构信息

Institut für Klinische Pharmakologie, Universitätsklinikum Charité der Humboldt-Universitätzn Berlin, Germany.

出版信息

Pharmacogenetics. 1996 Jun;6(3):269-72. doi: 10.1097/00008571-199606000-00012.

DOI:10.1097/00008571-199606000-00012

PMID:8807669

Abstract

摘要

相似文献

A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15.

Pharmacogenetics. 1996 Jun;6(3):269-72. doi: 10.1097/00008571-199606000-00012.

The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.CYP2D6基因多态性对墨西哥裔美国人右美沙芬代谢的影响。

J Clin Pharmacol. 2005 Nov;45(11):1230-5. doi: 10.1177/0091270005280755.

Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual.

Eur J Clin Pharmacol. 2009 Jan;65(1):97-100. doi: 10.1007/s00228-008-0559-6. Epub 2008 Sep 17.

Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.爱沙尼亚人群中异喹胍和S-美芬妥因的羟化表型及CYP2D6基因型

Pharmacol Toxicol. 1996 May;78(5):303-7. doi: 10.1111/j.1600-0773.1996.tb01379.x.

A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype.

Pharmacogenetics. 1999 Jun;9(3):287-93. doi: 10.1097/00008571-199906000-00003.

Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.CYP2D6.1、CYP2D6.10和CYP2D6.17的比较代谢能力及抑制谱

Drug Metab Dispos. 2007 Aug;35(8):1292-300. doi: 10.1124/dmd.107.015354. Epub 2007 Apr 30.

Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.健康中国人群中CYP2D6*10和*14等位基因的频率及其对CYP2D6代谢活性的影响。

Clin Pharmacol Ther. 2007 Jan;81(1):95-8. doi: 10.1038/sj.clpt.6100015.

CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.墨西哥杜兰戈州特佩瓦诺族裔美洲印第安人和梅斯蒂索人的CYP2D6基因分型与表型

J Clin Pharmacol. 2006 May;46(5):527-36. doi: 10.1177/0091270006287586.

Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.通过唾液分析并参考接受肾脏血液透析的中国患者的基因型来确定右美沙芬代谢表型。

Clin Pharmacol Ther. 1996 Apr;59(4):411-7. doi: 10.1016/S0009-9236(96)90109-5.

Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?具有超快代谢者表型的CYP2D6基因重复阴性个体中的多态性：CYP2D6*35等位基因在超快代谢中的作用？

Pharmacogenetics. 2001 Feb;11(1):45-55. doi: 10.1097/00008571-200102000-00006.

引用本文的文献

Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.临床 CYP2D6 基因分型等位基因选择推荐：分子病理学协会、美国病理学家学院、荷兰皇家药剂师协会药物遗传学工作组以及欧洲药物基因组学和个体化治疗学会的联合共识推荐。

J Mol Diagn. 2021 Sep;23(9):1047-1064. doi: 10.1016/j.jmoldx.2021.05.013. Epub 2021 Jun 10.

CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6 (*) 15 and (*) 35 Genotyping.CYP2D7序列变异干扰TaqMan CYP2D6（*）15和（*）35基因分型。

Front Pharmacol. 2016 Jan 12;6:312. doi: 10.3389/fphar.2015.00312. eCollection 2015.

CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.在临床试验环境中，CYP2D6基因分型作为一种替代表型分型来确定代谢状态的方法。

AAPS PharmSci. 2000;2(4):E33. doi: 10.1208/ps020433.

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.高加索人群中的细胞色素P450 2D6变体：等位基因频率及表型后果

Am J Hum Genet. 1997 Feb;60(2):284-95.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验